Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Melanoma and meta-analysis and BRAF[original query] |
---|
Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. The British journal of dermatology 2011 Apr 164 (4): 776-84. Lee J-H, Choi J-W, Kim Y |
The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis. PloS one 2012 7 (10): e47054. Safaee Ardekani Gholamreza, Jafarnejad Seyed Mehdi, Tan Larry, Saeedi Ardavan, Li Ga |
A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance. Molecular cancer therapeutics 2014 Jul 13 (7): 1918-28. Xia Junfeng, Jia Peilin, Hutchinson Katherine E, Dahlman Kimberly B, Johnson Douglas, Sosman Jeffrey, Pao William, Zhao Zhongmi |
Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis. Oncotarget 2017 11 8 (47): 83280-83291. Peng Ling, Wang Yina, Hong Yun, Ye Xianghua, Shi Peng, Zhang Junyan, Zhao Qio |
Efficacy and safety of PD-1 inhibitors for treating advanced melanoma: a systematic review and meta-analysis. Immunotherapy 2018 11 10 (15): 1293-1302. Li Jing, Gu Ji |
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis. Dermatologic therapy 2019 Oct e13145. Garzón-Orjuela Nathaly, Prieto-Pinto Laura, Lasalvia Pieralessandro, Herrera Daniel, Castrillón Johanna, González-Bravo Diana, Castañeda-Cardona Camilo, Rosselli Die |
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysis. Dermatologic therapy 2020 Aug e14135. Garzón-Orjuela Nathaly, Prieto-Pinto Laura, Lasalvia Pieralessandro, Herrera Daniel, Castrillón Johanna, González-Bravo Diana, Castañeda-Cardona Camilo, Rosselli Die |
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden) 2020 4 59 (7): 833-844. Ny L, Hernberg M, Nyakas M, Koivunen J, Oddershede L, Yoon M, Wang X, Guyot P, Geisler |
Prognostic Value of ctDNA Mutation in Melanoma: A Meta-Analysis. Journal of oncology 2021 2021 6660571. Zheng Yang, Sun Hongyan, Cong Lele, Liu Chenlu, Sun Qian, Wu Nan, Cong Xianli |
Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes. Genome medicine 2022 06 14 (1): 65. Wang Meng, Banik Ishani, Shain A Hunter, Yeh Iwei, Bastian Boris |
Systematic review and meta-analysis of genomic alterations in acral melanoma. Pigment cell & melanoma research 2022 3 35 (3): 369-386. Broit Natasa, Johansson Peter A, Rodgers Chloe B, Walpole Sebastian T, Hayward Nicholas K, Pritchard Antonia |
The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: